Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taurolidine vs Heparin for CVC Infection Prevention in Children with Intestinal Failure
NCT02515201Phase 4Unknown
- Sponsor
- Hospital de Clínicas de Porto Alegre
- Start
- Sep 2014
- Primary completion
- Mar 2015
01
Overview
Phase 4, randomised, open-label trial of taurolidine in catheter-related bloodstream infection (CRBSI), sponsored by Hospital de Clínicas de Porto Alegre. Primary endpoint: Catheter-Related Bloodstream Infection at 1 year. Status: unknown.
02
Drugs
taurolidine
03
Conditions
catheter-related bloodstream infection (CRBSI)
Beyond the preview
Go deeper on NCT02515201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02515201.